Publication Type:

Journal Article


International Journal of Pharmacy and Pharmaceutical Sciences, Volume 4, Number SUPPL.3, p.710-715 (2012)



atorvastatin, bromhexine, carbamazepine, copolymer, cremophor, drug solubility, eudragit, eudragit rs, famotidine, fenofibrate, furosemide, glipizide, human, liquisolid tablet formulation, macrogol 400, micellization, microcrystalline cellulose, naproxen, nonhuman, piroxicam, polysorbate, polysorbate 80, prednisolone, propranolol, propylene glycol, review, silicon dioxide, solvent, surfactant, sustained drug release, sustained release formulation, tablet formulation, wettability


Solubility is one of the important parameter to obtain desired concentration of drug in systemic circulation. Liquisolid technique is one of the most promising techniques to achieve enhanced solubility of poorly soluble drugs. This approach is suitable for immediate or sustained release formulations and this depends upon the solubility of the drug in the non volatile solvents. Non volatile solvents enhance the solubility of water insoluble drugs by formation of micelles and act as dispersants. For immediate release liquisolid compacts, the selection of solvent is based on high drug solubility and for sustained release, solvents with least solubilising capacity is selected. The solubility of drug in non volatile solvents can be revealed by differential scanning calorimetry (DSC) and X- ray powder diffraction (XRPD). Since there are no specific non-volatile liquid vehicles used in the preparation of liquisolid compacts, different non aqueous solvents have been used as non-volatile liquid vehicles in the preparation of immediate release and sustained release liquisolid tablets with different drugs. So selection of non volatile solvent in liquisolid technique is important to obtain immediate or sustained release formulation.


cited By (since 1996)0

Cite this Research Publication

D. Aa Baby, Saroj, Sa, and Sabitha, M., “Mechanism of solubility of liquisolid formulation in non volatile solvent: A review”, International Journal of Pharmacy and Pharmaceutical Sciences, vol. 4, pp. 710-715, 2012.